an overview of sequencing in mcrpc
Published 5 years ago • 82 plays • Length 4:59Download video MP4
Download video MP3
Similar videos
-
3:09
mcrpc: sequencing therapy
-
6:37
case 2: sequencing therapy in mcspc
-
1:12
dr. pal on sequencing abiraterone and enzalutamide in mcrpc
-
2:49
overall survival data in mcrpc
-
7:52
case 3: treatment after progression to mcrpc
-
39:14
urowebinar: applications of advance ultrasound in prostate cancer
-
18:21
decisional tools to determine need for biopsy and re-biopsy in men with elevated psas
-
19:15
prostate cancer genetics and genomics
-
10:01
evaluating the prognostic value of psma pet/ct in mcrpc
-
6:53
treatment sequencing in advanced ovarian cancer
-
26:27
role of chemotherapy and treatment sequencing
-
7:44
vision trial supports lupsma-targeting therapy for mcrpc | michael morris
-
28:36
role of chemotherapy, treatment sequencing in mcrpc and future directions
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
4:56
improving the prognosis for patients with mcrpc
-
5:57
managing bone metastasis in patients with mcrpc
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
5:53
impact of bone metastases in mcrpc
-
21:20
next generation sequencing of prostate tumors: use of individualized biomarkers
-
2:50
the differences between mcrpc and nmcrpc
-
3:38
precision medicine in mcrpc
-
16:07
profound trial shows increased rpfs in mcrpc patients with brca1, brca2, and atm mutations